UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "Zoloft20mgpermlkoncentrat-SE-PLC-MPD-BBDL",
"type" : "collection",
"entry" : [
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/Zoloft20mgpermlkoncentrat-SE-PLC-MPD",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "Zoloft20mgpermlkoncentrat-SE-PLC-MPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_Zoloft20mgpermlkoncentrat-SE-PLC-MPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Zoloft20mgpermlkoncentrat-SE-PLC-MPD</b></p><a name=\"Zoloft20mgpermlkoncentrat-SE-PLC-MPD\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-MPD\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-MPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100023206-00015504, <code>http://ema.europa.eu/fhir/eurdId</code>/2696</p><p><b>domain</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}\">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008 100000073991}\">Concentrate for oral solution</span></p><p><b>indication</b>: </p><div><p>Zoloft är indicerat för behandling av: Egentliga depressionsepisoder. Förebyggande av återkommande episoder med egentlig depression. Paniksyndrom med eller utan agorafobi. Tvångssyndrom (OCD) hos vuxna och barn/ungdomar i åldrarna 6-17 år. Social fobi. Posttraumatiskt stressyndrom (PTSD).</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}\">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000097678}\">sertraline</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Zoloft 20 mg/ml koncentrat till oral lösning</p><blockquote><p><b>part</b></p><p><b>part</b>: Zoloft</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 20 mg/ml</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: koncentrat till oral lösning</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 sv}\">Swedish</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/mpId",
"value" : "SE-100023206-00015504"
},
{
"system" : "http://ema.europa.eu/fhir/eurdId",
"value" : "2696"
}
],
"domain" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000004",
"code" : "100000000012",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000005003",
"code" : "200000005004",
"display" : "Current"
}
]
},
"combinedPharmaceuticalDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008",
"code" : "100000073991",
"display" : "Concentrate for oral solution"
}
]
},
"indication" : "Zoloft är indicerat för behandling av: Egentliga depressionsepisoder. Förebyggande av återkommande episoder med egentlig depression. Paniksyndrom med eller utan agorafobi. Tvångssyndrom (OCD) hos vuxna och barn/ungdomar i åldrarna 6-17 år. Social fobi. Posttraumatiskt stressyndrom (PTSD).",
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072051",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"classification" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000093533",
"code" : "100000097678",
"display" : "sertraline"
}
]
}
],
"name" : [
{
"productName" : "Zoloft 20 mg/ml koncentrat till oral lösning",
"part" : [
{
"part" : "Zoloft",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000002",
"display" : "Invented name part"
}
]
}
},
{
"part" : "20 mg/ml",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "koncentrat till oral lösning",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "sv",
"display" : "Swedish"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/Zoloft20mgpermlkoncentrat-SE-PLC-RA",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "Zoloft20mgpermlkoncentrat-SE-PLC-RA",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_Zoloft20mgpermlkoncentrat-SE-PLC-RA\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Zoloft20mgpermlkoncentrat-SE-PLC-RA</b></p><a name=\"Zoloft20mgpermlkoncentrat-SE-PLC-RA\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-RA\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/15504</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Zoloft20mgpermlkoncentrat-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100023206-00015504,http://ema.europa.eu/fhir/eurdId#2696; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Concentrate for oral solution; indication = Zoloft är indicerat för behandling av: Egentliga depressionsepisoder. Förebyggande av återkommande episoder med egentlig depression. Paniksyndrom med eller utan agorafobi. Tvångssyndrom (OCD) hos vuxna och barn/ungdomar i åldrarna 6-17 år. Social fobi. Posttraumatiskt stressyndrom (PTSD).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = sertraline</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 1999-12-29</p><p><b>holder</b>: <a href=\"Organization-LOC-100032008.html\">Organization Upjohn EESV</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>1999-12-29</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
"value" : "15504"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/Zoloft20mgpermlkoncentrat-SE-PLC-MPD"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
"code" : "100000072099",
"display" : "Valid"
}
]
},
"statusDate" : "1999-12-29",
"holder" : {
🔗 "reference" : "Organization/LOC-100032008"
},
"case" : {
"type" : {
"coding" : [
{
"system" : "https://ema.europa.eu/fhir/authorisationDateType",
"code" : "dateOfFirstAuthorisation",
"display" : "First Authorisation"
}
]
},
"dateDateTime" : "1999-12-29"
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Zoloft20mgpermlkoncentrat-SE-PLC-PPD",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "Zoloft20mgpermlkoncentrat-SE-PLC-PPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_Zoloft20mgpermlkoncentrat-SE-PLC-PPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: PackagedProductDefinition Zoloft20mgpermlkoncentrat-SE-PLC-PPD</b></p><a name=\"Zoloft20mgpermlkoncentrat-SE-PLC-PPD\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-PPD\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-PPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href=\"MedicinalProductDefinition-Zoloft20mgpermlkoncentrat-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100023206-00015504,http://ema.europa.eu/fhir/eurdId#2696; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Concentrate for oral solution; indication = Zoloft är indicerat för behandling av: Egentliga depressionsepisoder. Förebyggande av återkommande episoder med egentlig depression. Paniksyndrom med eller utan agorafobi. Tvångssyndrom (OCD) hos vuxna och barn/ungdomar i åldrarna 6-17 år. Social fobi. Posttraumatiskt stressyndrom (PTSD).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = sertraline</a></p><p><b>containedItemQuantity</b>: 1 Bottle<span style=\"background: LightGoldenRodYellow\"> (Details: 200000000014 code200000002111 = '200000002111')</span></p><p><b>description</b>: </p><div><p>Flaska, 60 ml</p>\n</div><h3>MarketingStatuses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}\">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}\">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}\">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/example/pcid"
}
],
"packageFor" : [
{
🔗 "reference" : "MedicinalProductDefinition/Zoloft20mgpermlkoncentrat-SE-PLC-MPD"
}
],
"containedItemQuantity" : [
{
"value" : 1,
"unit" : "Bottle",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002111"
}
],
"description" : "Flaska, 60 ml",
"marketingStatus" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072052",
"code" : "100000072083",
"display" : "Marketed"
}
]
}
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073497",
"display" : "Bottle"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003206",
"display" : "Glass type III"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
🔗 "reference" : "ManufacturedItemDefinition/Zoloft20mgpermlkoncentrat-SE-PLC-MID"
}
},
"amount" : {
"value" : 60,
"unit" : "millilitre(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633~200000000014",
"code" : "100000110662"
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/Zoloft20mgpermlkoncentrat-SE-PLC-MID",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "Zoloft20mgpermlkoncentrat-SE-PLC-MID",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_Zoloft20mgpermlkoncentrat-SE-PLC-MID\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ManufacturedItemDefinition Zoloft20mgpermlkoncentrat-SE-PLC-MID</b></p><a name=\"Zoloft20mgpermlkoncentrat-SE-PLC-MID\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-MID\"> </a><a name=\"hcZoloft20mgpermlkoncentrat-SE-PLC-MID-en-US\"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073991}\">Concentrate for oral solution</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002111}\">Bottle</span></p></div>"
},
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073991",
"display" : "Concentrate for oral solution"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002111",
"display" : "Bottle"
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100032008",
"resource" : {
"resourceType" : "Organization",
"id" : "LOC-100032008",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_LOC-100032008\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization LOC-100032008</b></p><a name=\"LOC-100032008\"> </a><a name=\"hcLOC-100032008\"> </a><a name=\"hcLOC-100032008-en-US\"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100032008</p><p><b>name</b>: Upjohn EESV</p></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/v1/locations",
"value" : "LOC-100032008"
}
],
"name" : "Upjohn EESV"
}
}
]
}
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
